Status
Conditions
Treatments
About
The aim of the study is, to study the efficacy of the ketogenic diet in delaying or preventing recurrence and tumor growth progression of patients who have been previously treated by concomitant chemoradiotherapy (6 months) for high-grade glial tumors.
It will be an open-label trial of nutritional intervention for up to 1 year. An interim analysis of the data will be carried out to assess safety, compliance and efficacy of the diet. This will be reviewed by both SHS and the Clinical trial team.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
40 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Nachum Vaisman, Prof'
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal